Zoetis 8-K, filed Aug 6, 2026

Summary

Zoetis appointed James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer effective August 17, 2026, with Saccaro joining from GE HealthCare where he was CFO; Wetteny Joseph will step down as CFO and remain as a Special Advisor to the CEO on financial matters until early 2027. Zoetis said Joseph's departure was not due to any disagreement over operations, policies, accounting, financial disclosure or internal controls.

Key points

• Saccaro's offer letter provides a $1,000,000 annual base salary, a target annual incentive of 100% of base salary, a $5,000,000 target long-term incentive opportunity, a $6,250,000 make-whole restricted stock unit award and a $1,250,000 make-whole cash award.
• Saccaro previously served as CFO of GE HealthCare since June 2023 and as EVP and CFO of Baxter International from July 2015 to May 2023.
• Joseph will continue receiving his current base salary, benefits and equity vesting through the earlier of February 28, 2027 or a mutually agreed termination date, and is eligible for separation benefits under Zoetis' Executive Severance Plan.
• The new CFO role combines the finance function with oversight of Global Manufacturing and Supply, and Saccaro will serve as principal financial officer and principal accounting officer.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.